$ARIA Recent Headlines 5 charts to watch 3:52 p.m. Jan.

New Post Public Reply Private Reply Replies (0) Message Board

Jan 17, 2014 at 2:26 PM

$ARIA Recent Headlines

5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck

Ariad Pharmaceuticals (ARIA) Is Today's Pre-Market Mover With Heavy Volume Stock 8:57 a.m. Today - TheStreet.com
Ariad +9%, reports commercial availability of Iclusig for adult CML patients 8:25 a.m. Today - Seeking Alpha
ARIAD Announces Commercial Availability of Iclusig for Patients with Refractory Philadelphia-Positive Leukemias in US 6:36 a.m. Today - benzinga.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Jan. 15, 2014 - benzinga.com
J.P. Morgan Healthcare Confab Live Blog: Day Two 10:29 a.m. Jan. 14, 2014 - TheStreet.com
Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA) 8:54 a.m. Jan. 14, 2014 - TheStreet.com
JMP bullish on Ariad Pharma 3:03 p.m. Jan. 13, 2014 - Seeking Alpha
UPDATE: JMP Securities Reiterates Coverage on ARIAD Pharmaceuticals, Sees Market Share Regain 10:51 a.m. Jan. 13, 2014 - benzinga.com
Is A Short Squeeze Ahead for Ariad Pharmaceuticals, Inc. (ARIA)? - Tale of the Tape 7:29 a.m. Jan. 13, 2014 - Zacks.com
Biotech Stock Mailbag: NeoStem, MannKind, Inovio 6:00 a.m. Jan. 10, 2014 - TheStreet.com
Some Stock Ideas For January 2014 9:28 a.m. Jan. 8, 2014 - Seeking Alpha
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Jan. 7, 2014 - TheStreet.com
ARIAD to Present at JPM Conference - Analyst Blog 6:00 p.m. Jan. 6, 2014 - Zacks.com
UPDATE: Ariad Pharmaceuticals Downgraded by Citigroup 10:42 a.m. Jan. 6, 2014 - benzinga.com
Citi negative on Sarepta, Ariad for 2014, shares slide 8:21 a.m. Jan. 6, 2014 - Seeking Alpha
Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More 7:53 a.m. Jan. 6, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:19 a.m. Jan. 6, 2014 - benzinga.com
A Strange Mix of Action 4:44 p.m. Jan. 3, 2014 - RealMoney.com
Patience and Prudence 10:39 a.m. Jan. 3, 2014 - RealMoney.com
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com

ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Today - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AprilAire Ups the Game in Home Air Quality Filters

Taking Indoor Air Quality to New Heights with AprilAire Ever stepped inside a home and thought, “It just feels fresher in here”? Well, AprilAire's new TriPure™ Technology might be the reason why from now on. They've rolled out their new line of high-performance air filters, and they want to have a word about your indoor air quality. As folks get more serious about...

FIBRA Prologis Posts Strong Q3 2026 Results Amid Market Trends

Decoding FIBRA Prologis' Latest Numbers Never a dull moment in industrial real estate, folks—and FIBRA Prologis (BMV:FIBRAPL 14) just dropped its third quarter earnings results for 2026, lighting a fire in its trajectory. On the surface, their numbers seem to belt out a victory anthem, but let's peel back the layers to understand what truly hums under the hood. A...

Unicycive Faces Stock Plunge and Legal Woes After FDA Setback

Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...

Platform9: Strategic Private Cloud Innovator Emerges

Shifting Sands in Private Cloud Infrastructure Here's a nugget for those keeping tabs on infrastructure shifts: Platform9 just got its ticket punched as a Major Player in the latest IDC MarketScape assessment for worldwide private cloud infrastructure software vendors. And if you've been in this game as long as I have, you know this isn't just a bit of puffery—the IDC...

deepset Strikes with AI Cost Solutions for Key Sectors

The AI Cost Conundrum: deepset's Strategic Leap deepset's latest move unleashes a fresh wind in the AI sector, tackling the financial drag from running high-caliber AI agents. With its Haystack Enterprise Platform, deepset isn't just coddling around the edges—it's going for the heart, where the budget bleeds most, and patching it up with a tech-savvy twist. Surfing the...

Granite Scandal: Ex-Employee Faces Serious Charges

Unmasking Trust Breach at Granite Telecommunications Just when you think you've seen it all, a new scandal rocks the boat. This time it's Granite Telecommunications getting dragged into the spotlight. Their former employee, George Meegan, has been slapped with some hefty criminal charges—larceny, filing a false tax return, and money laundering. This isn’t some...

Compass Hit by Securities Fraud Suit; Investor Action Urged

Trouble Brewing for Compass Investors Amidst Legal Storm In the tangled web of mergers and acquisitions, Compass, Inc. (NYSE: COMP) finds itself in a legal quagmire that has investors on edge. The stark reality of a securities fraud class action lawsuit has emerged, centered around Compass’s January 2026 merger with Anywhere Real Estate Inc. The Heart of the Allegations...

Ransomware Hits The Money Store, Data at Risk

Ransomware in the Mortgage Sector Feels like data breaches are the new rainy day—unwelcome and unavoidable. This time, the storm hit MLD Mortgage Inc., otherwise known as The Money Store. You’d think that with a name like that, they'd keep a tight grip on their data. But nope, they've got a mess on their hands, and Edelson Lechtzin LLP is on the case, poking into this...

Sony's Game-Changing Sensor Reshapes Medical Endoscopy

In a world where medical tech innovation can make the difference between life and death, Sony’s latest feat will turn some heads in the healthcare industry. This ain’t about another PlayStation release; we’re talking the IMX742 CMOS image sensor crafted for single-use endoscopes. As far as breakthroughs go, the microscopic square sensor packs a surprising punch by...

Fountain Life Clinches 'Longevity Clinic of the Year' Again

Fountain Life's Victory Lap in Longevity Medicine Well, look who's snagged the top spot again: Fountain Life. This outfit just made headlines by being named the 'Longevity Clinic of the Year' for 2026. What's remarkable is that it isn't their first rodeo—they've scored this accolade two consecutive years. And while the awards are nice, what's really worth watching is...